BioSpace News Archive

Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine

Seqirus, a global leader in influenza prevention, announced today that its cell-based quadrivalent influenza vaccine (QIVc) has received approval from Health Canada for use in people 9 years of age and older.

December 11, 2019
·
6 min read
FIDI Passes AI Milestone: 100,000 Patients Scanned by AI

The AI solution from Aidoc has identified and triaged thousands of urgent cases in CT scans, saving lives

December 11, 2019
·
3 min read
Job Trends

GI Alliance expands into a 6th state with GastroArkansas

GI Alliance, the nation’s largest independent gastroenterology services organization, announced a partnership with GastroArkansas.

December 11, 2019
·
2 min read
FDA

iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA

The Company and the FDA reached agreement on key aspects of the pivotal Phase 3 clinical trial program to support approval of Wafermine for the indication of acute moderate to severe pain.

December 11, 2019
·
3 min read
BioMidwest

Clarus Therapeutics Expands Executive Team in Preparation for Landmark Launch of JATENZO® (testosterone undecanoate) Capsules CIII

Clarus Therapeutics, Inc. announced the appointment of five senior leaders, each of whom bring valuable industry and category experience to the team.

December 11, 2019
·
13 min read
Deals

Science Interactive Group Acquires eScience Labs

With acquisition, Science Interactive Group established as the leader in distance learning content, lab products, services, and software

December 11, 2019
·
3 min read
Enrollment Complete for VALUE, the Prospective EU VasQ™ External Support Post-Market Study

Laminate Medical Technologies has announced the completion enrollment of the VALUE study for the VasQ™ External Support.

December 11, 2019
·
2 min read
Biotech Beach

EPA Office of Science and Technology Awards Tetra Tech a $21 Million Ecological and Human Health Contract

Tetra Tech, Inc. announced the U.S. Environmental Protection Agency’s Office of Science and Technology awarded Tetra Tech a $21 million, single-award contract to support the Agency’s mission in assessing and managing threats to ecological and human health.

December 11, 2019
·
2 min read
Deals

Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock

Forty Seven, Inc., a clinical stage immuno-oncology company, announced that it has commenced an underwritten public offering of $140,000,000 of shares of its common stock.

December 11, 2019
·
1 min read
Drug Development

PDS Biotechnology Announces Principal Investigator and Independent Data Monitoring Committee for its Phase 2 Clinical Collaboration with Merck

Study evaluating PDS0101-KEYTRUDA® (pembrolizumab) Combination in First Line Treatment of Metastatic Head and Neck Cancer expected to be initiated in Q1 2020

December 11, 2019
·
6 min read